CA
NZ
UK
AU
IND
US
Tenon Medical (NASDAQ:TNON), maker of the Catamaran SI Joint Fusion System used to treat sacroiliac joint dysfunction, is falling roughly 28% in pre-market trading on August 20, 2026, to $8.22 after a whipsaw session a day earlier. On August 19, TNON shares rocketed as …
Cosmos Health (NASDAQ:COSM) shares are rebounding sharply in pre-market trading after the company reported record second-quarter and first-half 2026 revenue. Full Q2 2026 results, released August 19, 2026, showed revenue of $18.99 million, up 28.8% year-over-year, with first-half revenue of $36.91 million, up 29.7%, …
Merck & Co. is one of the largest global pharmaceutical companies, with a diversified portfolio spanning oncology, vaccines, and other therapeutic areas. As a large-cap pharma name, MRK's price action tends to be driven by a mix of steady fundamental developments — drug approvals, …
Maravai LifeSciences Holdings is a life sciences company providing critical products used in nucleic acid production andBiologicssafety testing, including reagents and technologies that support mRNA-basedVaccineand therapeutic development. As a tools and reagents supplier rather than a clinical-stage drug developer, MRVI's price action tends to …
Key TakeawaysSana Biotechnology surged 12.95% (+$0.47) on Thursday to close at $4.10, breaking out decisively above both its 21-day EMA ($3.56) and 63-day EMA ($3.43) after months of trading below these key trend lines.The rally came onVolumeof 5.9 million shares, a sharp pickup versus …
BioNTech SE is a German biopharmaceutical company best known for its mRNA-basedVaccineand therapeutic platform, with an expanding pipeline spanning oncology, infectious disease, and other areas beyond its original COVID-19 vaccineFranchisedeveloped with Pfizer. As with many biopharma names of its scale, BNTX's share price has …
Twist Bioscience is a synthetic biology company known for its silicon-based DNA synthesis platform, which serves customers across biopharma, diagnostics, agriculture, and industrial chemical applications, as well as a growing DNA data storage business. As a company operating at the intersection of genomics and …
Twist Bioscience Corporation (NASDAQ: TWST) has been chosen as an independent evaluator by Anthropic PBC for a protein design initiative targeting 15 specific proteins. The announcement was made in a blog post by Anthropic on August 18, 2026. ThisPartnershipadvances Twist’s role in the rapidly …
Under these new agreements, Dr. Iwaki's annual base salary is established at $690,246, while Dr. Matsuda will earn $540,143 annually. This restructured compensation package is essential as it underscores the commitment of MediciNova to maintaining leadership continuity during this period.
Existing shareholders of Talkspace (NASDAQ: TALK) ceased to have any rights except for the cash compensation stipulated in the merger agreement.
Please wait processing your request...